Compile Data Set for Download or QSAR
maximum 50k data
Found 422 of ic50 data for polymerid = 8874,9799
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM312447(2-[6-Ethyl-3-(4-methyl-thiazol-2-yl)-4,5,6,7-tetra...)
Affinity DataIC50:  10nMAssay Description:Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM312356(2-[3-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-4,4-dim...)
Affinity DataIC50:  10nMAssay Description:Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM312347(3-[3-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-6-methy...)
Affinity DataIC50:  10nMAssay Description:Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM312342(2-[3-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-6-methy...)
Affinity DataIC50:  10nMAssay Description:Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM312421(2-[(S)-3-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-6-e...)
Affinity DataIC50:  13nMAssay Description:Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM312420(2-[3-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-6-ethyl...)
Affinity DataIC50:  13nMAssay Description:Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM234709(US9353102, 4.15)
Affinity DataIC50:  16nMpH: 7.5Assay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 μM to 0.003 μM final comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM312422(2-[(R)-3-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-6-e...)
Affinity DataIC50:  18nMAssay Description:Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM312472(2-[3-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-4,5,6,7...)
Affinity DataIC50:  19nMAssay Description:Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM312401(2-[6,6-Difluoro-3-(3-trifluoromethyl-[1,2,4]oxadia...)
Affinity DataIC50:  20nMAssay Description:Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM312405(2-[6,6-Difluoro-3-(4-methyl-thiazol-2-yl)-4,5,6,7-...)
Affinity DataIC50:  20nMAssay Description:Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM312313(2-[3-(3-Trifluoromethyl-[1,2,4]oxadiazol-5-yl)-4,5...)
Affinity DataIC50:  20nMAssay Description:Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM312363((−)-2-[3-(3-Cyclopropyl-[1,2,4]oxadiazol-5-y...)
Affinity DataIC50:  20nMAssay Description:Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM312338(2-[3-(4-Trifluoromethyl-thiazol-2-yl)-4,5,6,7-tetr...)
Affinity DataIC50:  20nMAssay Description:Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM312340(2-[3-(4-Trifluoromethyl-thiazol-2-yl)-4,5,6,7-tetr...)
Affinity DataIC50:  20nMAssay Description:Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM312346(2-[3-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-6-methy...)
Affinity DataIC50:  20nMAssay Description:Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM312330(2-[4,4-Dimethyl-3-(3-methyl-[1,2,4]oxadiazol-5-yl)...)
Affinity DataIC50:  20nMAssay Description:Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM312442(2-[3-(4-Methyl-thiazol-2-yl)-6-trifluoromethyl-4,5...)
Affinity DataIC50:  22nMAssay Description:Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM234707(US9353102, 4.13)
Affinity DataIC50:  22nMpH: 7.5Assay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 μM to 0.003 μM final comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM234703(US9353102, 4.9)
Affinity DataIC50:  22nMpH: 7.5Assay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 μM to 0.003 μM final comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM312398(2-[3-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-6,6-dif...)
Affinity DataIC50:  30nMAssay Description:Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM312386(2-[3-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-5,6-dih...)
Affinity DataIC50:  30nMAssay Description:Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM312460(2-[3-(3-Cyclopropyl-[1,2,4]thiadiazol-5-yl)-4,5,6,...)
Affinity DataIC50:  30nMAssay Description:Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM312485(2-[6,6-Difluoro-3-(4-isopropyl-thiazol-2-yl)-4,5,6...)
Affinity DataIC50:  30nMAssay Description:Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM234674(US9353102, 3.3)
Affinity DataIC50:  30nMpH: 7.5Assay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 μM to 0.003 μM final comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM234678(US9353102, 4.2)
Affinity DataIC50:  30nMpH: 7.5Assay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 μM to 0.003 μM final comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM234681(US9353102, 4.5)
Affinity DataIC50:  30nMpH: 7.5Assay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 μM to 0.003 μM final comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM234704(US9353102, 4.10)
Affinity DataIC50:  30nMpH: 7.5Assay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 μM to 0.003 μM final comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM234682(US9353102, 5)
Affinity DataIC50:  30nMpH: 7.5Assay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 μM to 0.003 μM final comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM312314(3-[3-(3-Trifluoromethyl-[1,2,4]oxadiazol-5-yl)-4,5...)
Affinity DataIC50:  30nMAssay Description:Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM312333(3-[3-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-benzo[b...)
Affinity DataIC50:  30nMAssay Description:Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM312341(3-[3-(4-Trifluoromethyl-thiazol-2-yl)-4,5,6,7-tetr...)
Affinity DataIC50:  30nMAssay Description:Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM312357(3-[3-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-4,4-dim...)
Affinity DataIC50:  30nMAssay Description:Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM312372(2-[5-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-3-thia-...)
Affinity DataIC50:  30nMAssay Description:Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM312378(2-[3-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-5,6,7,8...)
Affinity DataIC50:  30nMAssay Description:Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM312380(2-[3-(3-Trifluoromethyl-[1,2,4]oxadiazol-5-yl)-5,6...)
Affinity DataIC50:  30nMAssay Description:Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM312382(3-[3-(3-Trifluoromethyl-[1,2,4]oxadiazol-5-yl)-5,6...)
Affinity DataIC50:  30nMAssay Description:Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM312404(2-[6,6-Difluoro-3-(4-methyl-thiazol-2-yl)-4,5,6,7-...)
Affinity DataIC50:  30nMAssay Description:Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM234710(US9353102, 4.16)
Affinity DataIC50:  31nMpH: 7.5Assay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 μM to 0.003 μM final comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM234706(US9353102, 4.12)
Affinity DataIC50:  31nMpH: 7.5Assay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 μM to 0.003 μM final comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM312434(3-[(S)-6-Ethyl-3-(4-methyl-thiazol-2-yl)-4,5,6,7-t...)
Affinity DataIC50:  32nMAssay Description:Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM312423(3-[3-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-6-ethyl...)
Affinity DataIC50:  32nMAssay Description:Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM312453(2-[3-(3-Cyclopropyl-[1,2,4]thiadiazol-5-yl)-6,6-di...)
Affinity DataIC50:  33nMAssay Description:Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM312471(2-[5-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-3,4-dih...)
Affinity DataIC50:  34nMAssay Description:Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM312465(3-[3-(3-Cyclopropyl-[1,2,4]thiadiazol-5-yl)-4,5,6,...)
Affinity DataIC50:  34nMAssay Description:Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM312490(2-[3-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-5,5-dim...)
Affinity DataIC50:  38nMAssay Description:Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM234701(US9353102, 4.7)
Affinity DataIC50:  38nMpH: 7.5Assay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 μM to 0.003 μM final comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM234691(US9353102, 6.8)
Affinity DataIC50:  38.8nMpH: 7.5Assay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 μM to 0.003 μM final comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM234705(US9353102, 4.11)
Affinity DataIC50:  39nMpH: 7.5Assay Description:Stock DMSO solutions (1.8 mM) of compounds were serially diluted 3-fold for ten concentrations with 100% DMSO (50 μM to 0.003 μM final comp...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetFatty acid-binding protein 5(Homo sapiens (Human))
Hoffmann-La Roche

US Patent
LigandPNGBDBM312424(3-[(S)-3-(3-Cyclopropyl-[1,2,4]oxadiazol-5-yl)-6-e...)
Affinity DataIC50:  39nMAssay Description:Compounds were profiled for activity against human FABP4 (huFABP4) and/or human FABP5 (huFABP5) in Terbium (Tb) time resolved-fluorescence energy tra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 422 total ) | Next | Last >>
Jump to: